Literature DB >> 17855540

De novo synthesis of N and P proteins as a key step in Sendai virus gene expression.

Marian A Wiegand1, Sascha Bossow, Sabine Schlecht, Wolfgang J Neubert.   

Abstract

Among the members of the paramyxovirus family, the transcription process and the components involved have been studied under in vitro conditions thus far. Here, we reexamined the function of the viral RNA-dependent RNA polymerase through infection studies with Sendai virus (SeV) N and P deletion (Delta) mutants. To elucidate solely transcription-specific processes, all virus mutants also were rendered deficient in genome replication. Using mutant SeV DeltaP, the earlier suspected supplemental role of P protein was clearly demonstrated to be essential during viral gene expression. Moreover, when SeV DeltaN or DeltaN PDelta2-77 (with the 5' end of the P gene deleted) mutant was used for infections, a completely unexpected new and essential role for N protein was discovered for viral gene expression. In the early phases of an infection and in the absence of de novo viral protein synthesis, primary transcription occurs at hardly detectable levels. In contrast, if newly synthesized N protein is present, primary viral transcription reaches normal levels. From our data, we conclude that de novo synthesis of SeV N and P proteins is a key step for viral gene expression that facilitates the transition from preliminary to normal primary transcriptional activity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17855540      PMCID: PMC2168830          DOI: 10.1128/JVI.00914-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  28 in total

1.  Efficient propagation of single gene deleted recombinant Sendai virus vectors.

Authors:  Christian Bernloehr; Sascha Bossow; Guy Ungerechts; Sorin Armeanu; Wolfgang J Neubert; Ulrich M Lauer; Michael Bitzer
Journal:  Virus Res       Date:  2004-02       Impact factor: 3.303

2.  Mapping the phosphoprotein binding site on Sendai virus NP protein assembled into nucleocapsids.

Authors:  Bayram Cevik; Jeffrey Kaesberg; Sherin Smallwood; Joyce A Feller; Sue A Moyer
Journal:  Virology       Date:  2004-08-01       Impact factor: 3.616

Review 3.  Viral DNA polymerase scanning and the gymnastics of Sendai virus RNA synthesis.

Authors:  Daniel Kolakofsky; Philippe Le Mercier; Frédéric Iseni; Dominique Garcin
Journal:  Virology       Date:  2004-01-20       Impact factor: 3.616

4.  Dynamics of viral RNA synthesis during measles virus infection.

Authors:  Sébastien Plumet; W Paul Duprex; Denis Gerlier
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

5.  The synthesis of sendai virus polypeptides in infected cells.

Authors:  R A Lamb; B W Mahy; P W Choppin
Journal:  Virology       Date:  1976-01       Impact factor: 3.616

6.  Regulatory events in the synthesis of Sendai virus polypeptides and their assembly into virions.

Authors:  A Portner; D W Kingsbury
Journal:  Virology       Date:  1976-08       Impact factor: 3.616

7.  Localization of P, NP, and M proteins on Sendai virus nucleocapsid using immunogold labeling.

Authors:  A Portner; K G Murti
Journal:  Virology       Date:  1986-04-30       Impact factor: 3.616

8.  Negative-strand RNA viral vectors: intravenous application of Sendai virus vectors for the systemic delivery of therapeutic genes.

Authors:  Michael Bitzer; Guy Ungerechts; Sascha Bossow; Florian Graepler; Reinhard Sedlmeier; Sorin Armeanu; Christian Bernloehr; Martin Spiegel; Christine D Gross; Michael Gregor; Wolfgang J Neubert; Ulrich M Lauer
Journal:  Mol Ther       Date:  2003-02       Impact factor: 11.454

9.  Recombinant Sendai viruses expressing different levels of a foreign reporter gene.

Authors:  Tsuyoshi Tokusumi; Akihiro Iida; Takahiro Hirata; Atsushi Kato; Yoshiyuki Nagai; Mamoru Hasegawa
Journal:  Virus Res       Date:  2002-06       Impact factor: 3.303

10.  Altered ratios of measles virus transcripts in diseased human brains.

Authors:  R Cattaneo; G Rebmann; K Baczko; V ter Meulen; M A Billeter
Journal:  Virology       Date:  1987-10       Impact factor: 3.616

View more
  14 in total

1.  A new Ebola virus nonstructural glycoprotein expressed through RNA editing.

Authors:  Masfique Mehedi; Darryl Falzarano; Jochen Seebach; Xiaojie Hu; Michael S Carpenter; Hans-Joachim Schnittler; Heinz Feldmann
Journal:  J Virol       Date:  2011-03-16       Impact factor: 5.103

2.  Vesicular stomatitis virus as an oncolytic agent against pancreatic ductal adenocarcinoma.

Authors:  Andrea M Murphy; Dahlia M Besmer; Megan Moerdyk-Schauwecker; Natascha Moestl; David A Ornelles; Pinku Mukherjee; Valery Z Grdzelishvili
Journal:  J Virol       Date:  2012-01-11       Impact factor: 5.103

3.  A Respiratory Syncytial Virus Vaccine Vectored by a Stable Chimeric and Replication-Deficient Sendai Virus Protects Mice without Inducing Enhanced Disease.

Authors:  Marian Alexander Wiegand; Gianni Gori-Savellini; Claudia Gandolfo; Guido Papa; Christine Kaufmann; Eva Felder; Alessandro Ginori; Maria Giulia Disanto; Donatella Spina; Maria Grazia Cusi
Journal:  J Virol       Date:  2017-04-28       Impact factor: 5.103

4.  Identification of sendai virus L protein amino acid residues affecting viral mRNA cap methylation.

Authors:  Andrea M Murphy; Valery Z Grdzelishvili
Journal:  J Virol       Date:  2008-12-03       Impact factor: 5.103

5.  Cell type mediated resistance of vesicular stomatitis virus and Sendai virus to ribavirin.

Authors:  Nirav R Shah; Amanda Sunderland; Valery Z Grdzelishvili
Journal:  PLoS One       Date:  2010-06-22       Impact factor: 3.240

6.  Efficient Delivery of Human Cytomegalovirus T Cell Antigens by Attenuated Sendai Virus Vectors.

Authors:  Richard Kiener; Markus Fleischmann; Marian Alexander Wiegand; Niels A W Lemmermann; Christiane Schwegler; Christine Kaufmann; Angelique Renzaho; Simone Thomas; Eva Felder; Hans Helmut Niller; Benedikt Asbach; Ralf Wagner
Journal:  J Virol       Date:  2018-07-17       Impact factor: 5.103

7.  Breaking resistance of pancreatic cancer cells to an attenuated vesicular stomatitis virus through a novel activity of IKK inhibitor TPCA-1.

Authors:  Marcela Cataldi; Nirav R Shah; Sébastien A Felt; Valery Z Grdzelishvili
Journal:  Virology       Date:  2015-08-29       Impact factor: 3.616

8.  Sequence of events in measles virus replication: role of phosphoprotein-nucleocapsid interactions.

Authors:  Joanna Brunel; Damien Chopy; Marion Dosnon; Louis-Marie Bloyet; Patricia Devaux; Erica Urzua; Roberto Cattaneo; Sonia Longhi; Denis Gerlier
Journal:  J Virol       Date:  2014-07-09       Impact factor: 5.103

9.  A protein that replaces the entire cellular eIF4F complex.

Authors:  Mohammad A Mir; Antonito T Panganiban
Journal:  EMBO J       Date:  2008-10-30       Impact factor: 11.598

10.  Evaluation of nucleocapsid and phosphoprotein p functionality as critical factors during the early phase of paramyxoviral infection.

Authors:  Sascha Bossow; Sabine Schlecht; Rainer Schubbert; Matthias Pfeiffer; Wolfgang J Neubert; Marian Wiegand
Journal:  Open Virol J       Date:  2012-06-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.